Ionis Pharmaceuticals Inc (IONS)

Precedente Chiudi:

$43.01

Aprire:

$43.15

Volume 24 ore:

659.98K

Capitalizzazione di mercato:

$6.28B

Reddito:

$787.65M

Utile/perdita netta:

$-366.29M

Rapporto P/E:

-15.01

EPS:

-2.87

Flusso di cassa netto:

$-335.52M

1 W Prestazione:

+2.99%

1M Prestazione:

+0.21%

6M Prestazione:

-1.46%

1 anno Prestazione:

+21.31%

Intervallo 1D:

$42.62

$43.62

Portata 52W:

$34.32

$54.44

Ionis Pharmaceuticals Inc Stock (IONS) Company Profile

Nome

Ionis Pharmaceuticals Inc

Settore

Healthcare (1190)

Industria

Biotechnology (681)

Telefono

760-931-9200

Indirizzo

2855 Gazelle Court, Carlsbad, CA

Dipendente

547

Cinguettio

@ionispharma

Prossima data di guadagno

2024-05-14

Ultimi documenti SEC

IONS's Discussions on Twitter

Ionis Pharmaceuticals Inc Stock (IONS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-01-02	Aggiornamento	BofA Securities	Neutral → Buy
2023-10-23	Aggiornamento	BofA Securities	Underperform → Neutral
2023-09-29	Iniziato	Raymond James	Strong Buy
2023-07-31	Aggiornamento	Citigroup	Neutral → Buy
2023-06-07	Ripresa	Piper Sandler	Overweight
2023-05-04	Aggiornamento	Citigroup	Sell → Neutral
2023-03-21	Iniziato	Bernstein	Underperform
2022-12-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-09-09	Ripresa	Morgan Stanley	Overweight
2022-07-18	Ripresa	Oppenheimer	Outperform
2022-03-31	Ripresa	Piper Sandler	Overweight
2022-03-01	Iniziato	Citigroup	Sell
2022-03-01	Iniziato	Guggenheim	Buy
2022-02-01	Downgrade	BofA Securities	Buy → Underperform
2021-12-14	Aggiornamento	William Blair	Mkt Perform → Outperform
2021-05-07	Aggiornamento	UBS	Sell → Neutral
2021-03-01	Aggiornamento	Barclays	Underweight → Equal Weight
2020-12-16	Iniziato	UBS	Sell
2020-12-15	Aggiornamento	Cowen	Market Perform → Outperform
2020-09-14	Ripresa	JP Morgan	Neutral
2020-09-02	Iniziato	The Benchmark Company	Hold
2020-06-01	Ripresa	Oppenheimer	Outperform
2020-05-13	Iniziato	RBC Capital Mkts	Outperform
2020-03-05	Iniziato	Citigroup	Buy
2019-12-13	Iniziato	Oppenheimer	Outperform
2019-11-13	Iniziato	BofA/Merrill	Buy
2019-11-07	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2019-09-10	Aggiornamento	Bernstein	Mkt Perform → Outperform
2018-08-08	Reiterato	Stifel	Hold
2018-08-07	Reiterato	Stifel	Hold
2018-05-08	Downgrade	Evercore ISI	Outperform → In-line
2017-10-06	Ripresa	Goldman	Sell
2017-08-17	Iniziato	Evercore ISI	Outperform
2017-08-09	Reiterato	Stifel	Hold
2017-03-10	Downgrade	Goldman	Neutral → Sell
2016-12-28	Reiterato	BMO Capital Markets	Outperform
2016-12-27	Reiterato	Leerink Partners	Mkt Perform

Mostra tutto

Ionis Pharmaceuticals Inc Borsa (IONS) Ultime notizie

4D Molecular Therapeutics, Inc. (FDMT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks Investment Research

Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks Investment Research

The Latest Analyst Ratings For Ionis Pharmaceuticals

Benzinga

Can Ionis' (IONS) Wholly-Owned Drugs Cut Dependency on Collabs?

Zacks Investment Research

Ionis Pharmaceuticals (IONS) Down 2.8% Since Last Earnings Report: Can It Rebound?

Zacks Investment Research

Ionis (IONS) Drug Meets Mid-Stage MASH Study Goals

Zacks Investment Research

Ionis Pharmaceuticals Inc Azioni (IONS) Dati Finanziari

Ionis Pharmaceuticals Inc (IONS) Reddito 2024

Ionis Pharmaceuticals Inc (IONS) Reddito netto 2024

Ionis Pharmaceuticals Inc (IONS) Flusso di cassa 2024

Ionis Pharmaceuticals Inc (IONS) Utile per azione 2024

Ionis Pharmaceuticals Inc Azioni (IONS) insider trading